Home | Advanced Search | Downloads | Login | Contact Us
Company   Technology Platforms   Investor Relations   News & Information   Contact Us
02/18/2010 - Medline Industries to Sell BIOGUARD™ Wound Dressings with NIMBUS® Technology

Gainesville, Florida - February 18, 2010 - Quick-Med Technologies, Inc. (OTCBB: QMDT) announced today that its licensee, Derma Sciences, Inc. (NASDAQ: DSCI), has entered into an exclusive distribution agreement with Medline Industries whereby Medline will market and sell BIOGUARD™ wound dressings with Quick-Med's proprietary NIMBUS antimicrobial technology. The agreement covers the acute care segment of the health care market, which includes nearly 6,000 hospitals in the United States plus surgery centers, wound care centers, and other associated health care facilities. Sales under this new agreement are expected to start later this month.
Read More...
02/16/2010 - Quick-Med Technologies Expands NIMBUS® License for Derma Sciences' BIOGUARD™ Wound Dressings

Gainesville, Florida - February 16, 2010 - Quick-Med Technologies, Inc. (OTCBB: QMDT) announced today that it has amended its Patent and Technology License Agreement with Derma Sciences, Inc. (NASDAQ: DSCI) to grant Derma Sciences rights to use NIMBUS® technology in an expanded range of wound dressings formats marketed by Derma Sciences under its BIOGUARD™ trademark. The amendment also adjusts minimum royalties, provides terms for Derma Sciences entering into a private-label contract, and extends the term of the License for an additional three years subject to Derma Sciences meeting certain milestones and performance requirements.
Read More...
11/16/2009 - Quick-Med Technologies Receives First Royalties for its NIMBUS® Wound Dressings

Gainesville, Florida - November 16, 2009 - Quick-Med Technologies, Inc. (OTCBB: QMDT) announced today that the Company has begun to receive royalty payments for its novel NIMBUS® non-leaching antimicrobial technology. The royalty payment is from Quick-Med licensee Derma Sciences, Inc. (OTCBB: DSCI) for initial sales of its BIOGUARD™ dressings.
Read More...
10/23/2009 - FDA Issues Guidance for Quick-Med Technologies' Exclusive Wound Dressing with pDADMAC

Gainesville, Florida - October 23, 2009 - Quick-Med Technologies, Inc. (OTCBB: QMDT) announced today that the Food and Drug Administration has issued Guidance to support the classification of the Company's NIMBUS® barrier gauze wound dressings as Class II medical devices. This novel wound dressing received its initial market clearance on February 25, 2009 via FDA's De Novo review process, a special clearance program for medical devices that are found to be "not substantially equivalent" to any predicate device.
Read More...
10/14/2009 - USPTO and WIPO Publish NimbuDerm™ Patent Applications

Gainesville, Florida - October 14, 2009 - Quick-Med Technologies, Inc. (OTCBB: QMDT), a pioneer in advanced antimicrobial technologies for medical and consumer applications, announced today that the United States Patent and Trademark Office and the World Intellectual Property Organization have published Company patent applications covering Disinfectant Alcohol-Soluble Quaternary Ammonium Polymers.
Read More...
10/02/2009 - Quick-Med Technologies to Present NIMBUS at Prestigious Clinical Symposium on Advances in Skin &Wound Care
09/23/2009 - Quick-Med Technologies Announces the Development of Stay Fresh™ Textiles Technology
06/25/2009 - Quick-Med Technologies Announces First Commercial Sales of NIMBUS® Wound Care Products
04/23/2009 - Quick-Med and Avery Dennison Enter Into Joint Development Agreement
04/09/2009 - Quick-Med Technologies to Present NIMBUS at the Symposium on Advanced Wound Care and Wound Healing Society Meeting
03/24/2009 - Quick-Med and Foster Enter Into Joint Development Agreement
11/18/2008 - New Study Reaffirms Quick-Med's NIMBUS® Technology Poses No Threat of Bacterial Resistance
06/11/2008 - Quick-Med Technologies,, Inc. Signs Manufacturing and Distribution Agreement with BASF Beauty Care Solutions
05/21/2008 - NIMBUS®, NimbuDerm™ and MultiStat™ Technologies Selected for Presentation at Prestigious 3rd Congress of the World Union of Wound Healing Societies in Toronto
05/15/2008 - Quick-Med's Novel Wound Dressing Receives Recognition from the Wound Healing Society
05/14/2008 - NimbuDerm™ Receives Wound Healing Society's Blue Ribbon Award
04/08/2008 - Quick-Med Technologies Presenting at Prestigious SAWC/WHS Conference
03/11/2008 - Quick-Med Technologies is Developing a Next Generation Skin Sanitizer Technology to Provide Long-Lasting Protection from MRSA
02/12/2008 - Quick-Med Technologies' Research & Development Center Moves to New Location
02/01/2008 - Dr. Olderman Highlights the Value of a Bonded Antimicrobial at Textiles Conference
12/04/2007 - Dr. Olderman to Highlight Antimicrobial Protection in Textiles Applications at Orlando Conference
09/11/2007 - Quick-Med Technologies Appoints J. Ladd Greeno to Its Board of Directors
08/09/2007 - Quick-Med Technologies Announces CEO Appointment
08/02/2007 - Mexico grants Quick-Med Technologies, Inc. Notice of Allowance for its NIMBUS® Technology
06/19/2007 - Quick-Med Technologies, Inc. and the University of Michigan Sign Patent Licensing Agreement
04/24/2007 - Quick-Med Technologies, Inc. Awarded $1 Million Congressional Appropriation
04/02/2007 - Quick-Med Technologies, Inc. Licenses NIMBUS Antimicrobial Technology To Derma Sciences, Inc. For Use In Wound Care Products
03/26/2007 - Quick-Med Technologies' Lead Molecule Ilomastat Selected for Evaluation in Sulfur Mustard Gas Grant from NIH
 

09/22/2006 - Quick-Med Technologies, Inc. Confirms U.S. Army Contract For Phase II SBIR Grant
07/10/2006 - Quick-Med Technologies, Inc. Resolves Dispute With Cosmetics Distribution Partner
26/07/2006 - Quick-Med Technologies, Inc. Competitively Selected By U.S. Army For a $770,000 Phase II SBIR Grant
06/01/2006 - Quick-Med Technologies, Inc. to Address Congressional 21st Century Health Care Caucus on Hospital Infection Prevention
05/31/2006 - Quick-Med Technologies, Inc. Receives Wound Healing Society's Prestigious Blue Ribbon Award

03/16/2006 - Quick-Med Technologies, Inc. Senior Scientist Gregory S. Schultz Profiled in TIME Magazine
09/01/2006 - Cheryl L. Turnbull Elected to Board of Directors of Quick-Med Technologies, Inc.

 

12/08/2005 - Quick-Med Technologies, Inc. Receives Key Patent On Its NIMBUS™ Technology U.S. Patent Allowance Significantly Strengthens Overall Patent Portfolio
11/15/2005 - Quick-Med Technologies, Inc. Awarded U.S. Army SBIR Phase I Contract
09/13/2005 - Quick-Med Technologies, Inc. and The University of Florida Collaborate to Develop The Next Generation of NIMBUS™ Antimicrobial Technology

01/13/2005 - Quick-Med Technologies, Inc. Retains Elman Technology Law, P.C.
01/05/2005 - Quick-Med Technologies, Inc. Raises Additional $1 Million in Equity Capital
 
12/23/2004 - Press Release Quick-Med Technologies, Inc. Signs Research Agreement with Johnson & Johnson Wound Management
07/19/2004 - Quick-Med Technologies, inc. Signs Agreement with Morgan Keegan & Company, Inc. to Serve as Exclusive Financial Advisor
04/15/2004 - Quick-Med Technologies Receives Key U.S. Patent
03/15/2004 - Richard F. Caffrey, president of R. F. Caffrey & Associates, Inc., appointed to Quick-Med Technologies Inc.’s Board of Directors
 
09/24/2003 - Quick-Med Technologies, Inc. Licenses Key New Patents For Skin Care
07/01/2003 - Quick-Med Technologies, Inc. Announces Completion of Initial Phase of Cosmetic Development Program and Product Launch
06/24/2003 - Quick-Med Technologies, Inc. Reports Success of NIMBUS™ in Preventing Mold, Second Joint Development Agreement in Building Materials Industry
06/03/2003 - Quick-Med Technologies, Inc. Announces Successful Clinical Results For Ilomastat
04/22/2003 - Quick-Med Technologies, Inc. Announces 2nd Key Clinical Success For Ilomastat
04/15/2003 - Quick-Med Technologies, Inc. Postpones Debt Financing Citing Lower-Cost Alternatives
03/18/2003 - Quick-Med Technologies Announces Non-Exclusive Joint Development Agreement for Wood Preservation
03/06/2003 - Quick-Med Technologies, Inc. Announces 2nd Key Clinical Success For Ilomastat
03/05/2003 - Quick-Med Technologies, Inc. Announces $2 Million Financing
03/03/2003 - Statement From The Board of Directors & Officers of Quick-Med Technologies, Inc. with Respect to Sale of Common Stock
02/19/2003 - Technology, Profiled In the Business Section of February 13, 2003 Gainesville Sun
02/11/2003 - Quick-Med Technologies Announces Next Phase of Development for Chemical Defense Product
 
12/03/2002 - Quick-Med Technologies, Inc. Obtains Key License Agreement with the University of Florida
11/19/2002 - Quick-Med Technologies Inc. Chairman Comments on Recent Development
09/09/2002 - Quick-Med Technologies Inc. Announces Distribution Agreement with the Collaborative Group
09/04/2002 - Quick-Med Technologies Inc. Announces Commencement of Trading and Introduces Management Team
 
News & Information
News Archive
Article Archive
Events

Enlarge Text Tool
Increase Text Size Decrease Text Size

 

Company | Technology Platforms | Investor Relations | News & Information | Contact Us | Search | Terms of Use
Copyright ©2002-2008 Quick-Med Technologies Inc. All Rights Reserved.